Old Web
English
Sign In
Acemap
>
authorDetail
>
Kate Flanders
Kate Flanders
Medicine
in patient
Endosomal membrane
Clinical trial
Oncology
2
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
VLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
2020
Blood
Michael Wang
Jacqueline C. Barrientos
Richard R. Furman
Matthew Mei
Paul M. Barr
Michael Y. Choi
Sven de Vos
Avyakta Kallam
Krish Patel
Simon Rule
Kate Flanders
Katti Jessen
Peter C. Riebling
Patricia Graham
Lydia B King
Elizabeth M. Schmidt
Brian Lannutti
David Michael Johnson
Langdon L. Miller
Stephen E. Spurgeon
Show All
Source
Cite
Save
Citations (8)
Phase 1 Clinical Safety, Pharmacokinetics (PK), and Activity of Apilimod Dimesylate (LAM-002A), a First-in-Class Inhibitor of Phosphatidylinositol-3-Phosphate 5-Kinase (PIKfyve), in Patients with Relapsed or Refractory B-Cell Malignancies
2017
Blood
Wael A. Harb
Catherine S. Diefenbach
Nehal Lakhani
Sarah C. Rutherford
Marshall T. Schreeder
Stephen Maxted Ansell
Taimur Sher
David M. Aboulafia
Jonathon B. Cohen
Darrell Nix
Sean Landrette
Kate Flanders
Langdon L. Miller
Henri Lichenstein
Jeremy S. Abramson
Show All
Source
Cite
Save
Citations (8)
1